Reported Earlier, Mainz Biomed Prices $4M Offering Of Shares And Warrants At $2/Unit To Support Cancer Diagnostics Strategy

Each unit is being sold at an effective offering price of $2.00 per unit. Each Series A warrant will be immediately exercisable at an exercise price of $2.00 per share and will expire five years from the date of issuance.